Petros Pharmaceuticals Inc (PTPI): In Feb 80% of Lowest 3 closing prices, i...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	471
Posts	29508
Boards Moderated	1
Alias Born	11/12/2016

KeepItRealistic

Re: runncoach post# 509

Sunday, 03/03/2024 7:00:53 PM

Sunday, March 03, 2024 7:00:53 PM

In Feb 80% of Lowest 3 closing prices, in last 30 days prior to Payment date was .8 x $1.13

$1,154.000 / (.8x$1.13) = 1.287,946

So 1,287,946 shares were added to float for the Feb Payment

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent PTPI News

Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2024 09:32:03 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/29/2023 09:05:18 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 09:05:32 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/26/2023 10:07:49 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/26/2023 10:06:56 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/26/2023 10:05:30 PM
Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 11/30/2023 09:07:41 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/30/2023 09:05:37 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/15/2023 10:11:15 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 10:00:18 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 12:00:18 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/19/2023 08:36:46 PM
Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 09/15/2023 09:16:43 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/15/2023 08:22:06 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/25/2023 09:08:39 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/15/2023 09:03:50 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 08/15/2023 09:01:13 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 09:03:00 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 08/11/2023 08:31:07 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 08:41:57 PM

More PTPI News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover